Home » Fda » What does DCEPT (CBER) mean in Fda?

DCEPT (CBER) in Fda Meaning

The DCEPT (CBER) meaning in Fda terms is "Division of Clinical Evaluation and Pharmacology/Toxicology (CBER)". There are 1 related meanings of the DCEPT (CBER) Fda abbreviation.

DCEPT (CBER) on Fda Full Forms

  1. Division of Clinical Evaluation and Pharmacology/Toxicology (CBER)

Frequently Asked Questions (FAQ)

  1. What does DCEPT (CBER) stand for Fda?

    DCEPT (CBER) stands for Division of Clinical Evaluation and Pharmacology/Toxicology (CBER) in Fda terms.

  2. What is the shortened form of Division of Clinical Evaluation and Pharmacology/Toxicology (CBER) in Fda?

    The short form of "Division of Clinical Evaluation and Pharmacology/Toxicology (CBER)" is DCEPT (CBER) for Fda.

Citation

DCEPT (CBER) in Fda. Acronym24.com. (2020, May 24). Retrieved November 25, 2024 from https://acronym24.com/dcept-cber-meaning-in-fda/

Last updated